76 related articles for article (PubMed ID: 16101162)
1. Evaluation of a dysfunctional and short-lived subset of monocyte-derived dendritic cells from cancer patients.
Onishi H; Morisaki T; Kuroki H; Matsumoto K; Baba E; Kuga H; Tanaka M; Katano M
Anticancer Res; 2005; 25(5):3445-51. PubMed ID: 16101162
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas.
Katano M; Morisaki T; Koga K; Nakamura M; Onishi H; Matsumoto K; Tasaki A; Nakashima H; Akiyoshi T; Nakamura M
Anticancer Res; 2005; 25(6A):3771-6. PubMed ID: 16302738
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
[TBL] [Abstract][Full Text] [Related]
5. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
[TBL] [Abstract][Full Text] [Related]
6. Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.
Kumagi T; Akbar SM; Horiike N; Kurose K; Hirooka M; Hiraoka A; Hiasa Y; Michitaka K; Onji M
Oncol Rep; 2005 Oct; 14(4):969-73. PubMed ID: 16142359
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional and short-lived subsets in monocyte-derived dendritic cells from patients with advanced cancer.
Onishi H; Morisaki T; Baba E; Kuga H; Kuroki H; Matsumoto K; Tanaka M; Katano M
Clin Immunol; 2002 Dec; 105(3):286-95. PubMed ID: 12498810
[TBL] [Abstract][Full Text] [Related]
9. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
Shilyansky J; Jacobs P; Doffek K; Sugg SL
J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells.
Tasaki A; Yamanaka N; Kubo M; Matsumoto K; Kuroki H; Nakamura K; Nakahara C; Onishi H; Kuga H; Baba E; Tanaka M; Morisaki T; Katano M
J Immunol Methods; 2004 Apr; 287(1-2):79-90. PubMed ID: 15099757
[TBL] [Abstract][Full Text] [Related]
11. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
12. HBsAg loading on dendritic cells in patients with chronic hepatitis B: expressions of phenotypic molecules.
Tong HS; Zhang Y; Yuan K; Fu XW
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):56-9. PubMed ID: 16481284
[TBL] [Abstract][Full Text] [Related]
13. Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-beta.
Zhang LF; Okuma K; Tanaka R; Kodama A; Kondo K; Ansari AA; Tanaka Y
Exp Biol Med (Maywood); 2008 Jun; 233(6):721-31. PubMed ID: 18408138
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional regulation of the development of monocyte-derived dendritic cells in cancer patients.
Hasebe H; Nagayama H; Sato K; Enomoto M; Takeda Y; Takahashi TA; Hasumi K; Eriguchi M
Biomed Pharmacother; 2000 Jul; 54(6):291-8. PubMed ID: 10989961
[TBL] [Abstract][Full Text] [Related]
16. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
17. Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro.
Dopheide JF; Sester U; Schlitt A; Horstick G; Rupprecht HJ; Münzel T; Blankenberg S
Coron Artery Dis; 2007 Nov; 18(7):523-31. PubMed ID: 17925605
[TBL] [Abstract][Full Text] [Related]
18. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
19. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
[TBL] [Abstract][Full Text] [Related]
20. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
